C. Aylesworth

Statistics

Publications

Citations

291

H-Index

Active since

1998

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Brooke Army Medical Center

Wilford Hall Ambulatory Surgical Center

C. Aylesworth is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, pharmacokinetics of anticancer agents, and oncology.

Publications per year

1998–2000

Publications

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

Eric K. Rowinsky, Lee Smith, Y M Wang et al. · Journal of Clinical Oncology · 1998 · 146 citations

Medicine, Oncology, Pharmacology +17

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss et al. · Annals of Oncology · 1998 · 76 citations

Medicine, Oncology, Pharmacology +10

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies.

Miguel A. Villalona‐Calero, Sharyn D. Baker, L. A. Hammond et al. · Journal of Clinical Oncology · 1998 · 32 citations

Medicine, Oncology, Pharmacology +12

A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors

Anthony W. Tolcher, C. Aylesworth, Jinee Rizzo et al. · Annals of Oncology · 2000 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

A phase I study of docetaxel and 5-fluorouraciI in patients with advanced solid malignancies

Thierry Petit, C. Aylesworth, Howard A. Burris et al. · Annals of Oncology · 1999 · 16 citations · Full text

Medicine, Oncology, Pharmacology +8

1–5 of 5